日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer

HER2低表达转移性三阴性乳腺癌的雄激素受体表达和免疫特征

Tarantino, Paolo; Cha, Jaeyoon; Binboga Kurt, Busem; Chu, Xiangying; Jovanović, Bojana; Zhou, Andrew; Hughes, Melissa; Russo, Douglas; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Lin, Nancy U; Carter, Jamie; Chen, Yisang Serenity; Li, Tianyu; Tayob, Nabihah; Mittendorf, Elizabeth A; Schnitt, Stuart J; Goel, Shom; Tolaney, Sara M

Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial

新辅助紫杉醇联合帕博利珠单抗治疗激素受体阳性乳腺癌的疗效、安全性及预测性生物标志物:一项随机试点试验

Waks, Adrienne G; Fu, Jingxin; Chu, Xiangying; Binboga Kurt, Busem; Li, Tianyu; Kuntz, Thomas M; Shen, Yizhuo; Yang, David; Meli, Kevin; Reardon, Brendan; Park, Jihye; Partridge, Ann; Abravanel, Daniel; Jeselsohn, Rinath; Wrabel, Eileen; Alberti, Jillian; DiLullo, Molly; Chen, Serenity; Mohammed-Abreu, Ayesha; Sun, Xiaopeng; Balko, Justin M; Kleijn, Miranda; Audeh, William; Morgan, Xochitl C; Krop, Ian E; Tayob, Nabihah; Van Allen, Eliezer M; Mittendorf, Elizabeth A; Tolaney, Sara M

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

早期原发性激素受体阳性乳腺癌抗PD-1和化疗期间的细胞重编程

Fu, Jingxin; Waks, Adrienne G; Pimenta, Erica; Titchen, Breanna; Bi, Kevin; Camp, Sabrina; Pappa, Theodora; Keenan, Tanya; Shannon, Erin; Vigneau, Sébastien; Bemus, Meredith; Nag, Anwesha; Thorner, Aaron R; Park, Jihye; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Mittendorf, Elizabeth A; Abravanel, Daniel L; Tolaney, Sara M; Van Allen, Eliezer M

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

一项针对转移性激素受体阳性乳腺癌或晚期卵巢癌患者的I期研究,评估了ribociclib(CDK4/6抑制剂)联合spartalizumab(PD-1抑制剂)以及单独使用或不联合fulvestrant的疗效。

Ana C Garrido-Castro ,Noah Graham ,Lestat R Ali ,Christina Herold ,Jennifer Desrosiers ,Khanh Do ,Heather Parsons ,Tianyu Li ,Shom Goel ,Molly DiLullo ,Eileen Wrabel ,Amy J Williams ,Joyce F Liu ,Elizabeth A Mittendorf ,Stephanie K Dougan ,Nabihah Tayob ,Geoffrey I Shapiro ,Sara M Tolaney

A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer

一项针对视网膜母细胞瘤阳性、转移性三阴性乳腺癌患者的阿贝西利II期研究

Goel, Shom; Jovanović, Bojana; Chu, Xiangying; Hughes, Melissa; Erick, Timothy K; Russo, Douglas; DiLullo, Molly; Wrabel, Eileen; Jeselsohn, Rinath; Lin, Nancy U; Tayob, Nabihah; Mittendorf, Elizabeth; Schnitt, Stuart; Tolaney, Sara M

Microendoscopy for periodic intravital end-to-end tumor imaging of cancer cells.

微型内窥镜用于定期对癌细胞进行活体肿瘤端到端成像

Goto Toshiyuki, Nakano Masayuki, Danno Sally, Ueda Chie, Sakaue-Sawano Asako, Miyawaki Atsushi, Wrabel Anna, Nakahara Ichiro, Nishikata Takahito, Mizoguchi Akira, Tamura Yasuhisa, Mizuno Kei, Kataoka Yosky, Funabiki Kazuo

The Modified Dosages for Acute Malnutrition (MODAM) study: protocol for three integrated randomized controlled trials of novel approaches for the management of childhood wasting in Ethiopia

改良急性营养不良剂量(MODAM)研究:埃塞俄比亚儿童消瘦症新型治疗方法的三个综合随机对照试验方案

Trehan, Indi; Beyene, Yosef; Darsene, Hiwot; Adams, Bailey S; Wrabel, Maria; Gizaw, Getu; Legese, Liya A; Cichon, Bernardette; Chitekwe, Stanley; Shellemew, Mesfin W; Tessema, Masresha; Stobaugh, Heather C

Mesopic and glare driving performance in a driving simulator

驾驶模拟器中中间视觉和眩光下的驾驶性能

Kerwin, Thomas; Wrabel, Cameron; Yu, Deyue; Lu, Zhong-Lin; Yang, Jingzhen

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

依西美坦联合依维莫司和帕博西尼治疗转移性乳腺癌:I/II期试验中的临床反应和基因组/转录组耐药性决定因素

Gómez Tejeda Zañudo, Jorge; Barroso-Sousa, Romualdo; Jain, Esha; Jin, Qingchun; Li, Tianyu; Buendia-Buendia, Jorge E; Pereslete, Alyssa; Abravanel, Daniel L; Ferreira, Arlindo R; Wrabel, Eileen; Helvie, Karla; Hughes, Melissa E; Partridge, Ann H; Overmoyer, Beth; Lin, Nancy U; Tayob, Nabihah; Tolaney, Sara M; Wagle, Nikhil

Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer

taselisib (GDC-0032) 联合 HER2 靶向疗法治疗晚期 HER2 阳性乳腺癌患者的 Ib 期剂量递增试验

Grinshpun, A; Ren, S; Graham, N; DeMeo, M K; Wrabel, E; Carter, J; Tayob, N; Pereslete, A; Hamilton, E; Juric, D; Mayer, E L; Tolaney, S M; Krop, I E; Metzger, O